Defibrotide Sodium and Moxetumomab Pasudotox-tdfk
Determining the interaction of Defibrotide Sodium and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: defibrotide
Brand name: Defitelio
Synonyms: Defibrotide
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Defibrotide Sodium-Moxetumomab pasudotox-tdfk Intravenous
- Defibrotide Sodium-Moxifloxacin
- Defibrotide Sodium-Moxifloxacin (Systemic)
- Defibrotide Sodium-Moxifloxacin Hydrochloride
- Defibrotide Sodium-Moxifloxacin Injection
- Defibrotide Sodium-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Definity
- Moxetumomab Pasudotox-tdfk-Defitelio
- Moxetumomab Pasudotox-tdfk-Deflazacort
- Moxetumomab Pasudotox-tdfk-Deflazacort Oral Suspension
- Moxetumomab Pasudotox-tdfk-Deflazacort Tablets
- Moxetumomab Pasudotox-tdfk-Deflux